Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Tang

Showing results (31-40 of 172) with videos related to

Pageof 18
Sort By:
Pharmacology, Biochemistry, and Behavior|February 1, 1984
Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP)A H Tang, A A Cangelosi, R A Code, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activityA H Tang, S R Franklin, C S Himes, et al.
Development (Cambridge, England)|February 15, 2001
Transcriptional regulation of cytoskeletal functions and segmentation by a novel maternal pair-rule gene, lilliputianA H Tang, T P Neufeld, G M Rubin, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1991
Exogenous NGF affects cholinergic transmitter function and Y-maze behavior in aged Fischer 344 male ratsL R Williams, R J Rylett, H C Moises, et al.
Brain Research|February 10, 1987
Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonistR C Silvia, G R Slizgi, J H Ludens, et al.
Brain Research|October 20, 1987
Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory tracesM F Piercey, G D Vogelsang, S R Franklin, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1983
Biochemical, functional and behavioral evaluation of a series of novel antipsychotic-like agentsP F Von Voigtlander, R A Lahti, A H Tang, et al.
Journal of Medicinal Chemistry|March 18, 1994
Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptorR E TenBrink, W B Im, V H Sethy, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypesA H Tang, M W Smith, D B Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological propertiesA H Tang, S R Franklin, C S Himes, et al.
Pageof 18

Showing results (31-40 of 172) with videos related to

Sort By:
Pageof 18
Pharmacology, Biochemistry, and Behavior|February 1, 1984
Phencyclidine-like behavioral effects of 2-methyl-3,3-diphenyl-3-propanolamine (2-MDP)A H Tang, A A Cangelosi, R A Code, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activityA H Tang, S R Franklin, C S Himes, et al.
Development (Cambridge, England)|February 15, 2001
Transcriptional regulation of cytoskeletal functions and segmentation by a novel maternal pair-rule gene, lilliputianA H Tang, T P Neufeld, G M Rubin, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1991
Exogenous NGF affects cholinergic transmitter function and Y-maze behavior in aged Fischer 344 male ratsL R Williams, R J Rylett, H C Moises, et al.
Brain Research|February 10, 1987
Protection from ischemia-induced cerebral edema in the rat by U-50488H, a kappa opioid receptor agonistR C Silvia, G R Slizgi, J H Ludens, et al.
Brain Research|October 20, 1987
Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: implications regarding identification of brain structures involved in consolidation of memory tracesM F Piercey, G D Vogelsang, S R Franklin, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|November 1, 1983
Biochemical, functional and behavioral evaluation of a series of novel antipsychotic-like agentsP F Von Voigtlander, R A Lahti, A H Tang, et al.
Journal of Medicinal Chemistry|March 18, 1994
Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptorR E TenBrink, W B Im, V H Sethy, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypesA H Tang, M W Smith, D B Carter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
PNU-96415E, a potential antipsychotic agent with clozapine-like pharmacological propertiesA H Tang, S R Franklin, C S Himes, et al.
Pageof 18